Cargando…
Current developments in endovascular therapy of peripheral vascular disease
More than 200 million people worldwide have peripheral artery disease (PAD) or its most severe manifestation, critical limb ischemia (CLI). While endovascular treatment has become first line therapy in most cases, a number of challenges remain for optimal treatment of femoropopliteal (FP) or infrapo...
Autores principales: | Kokkinidis, Damianos G., Armstrong, Ehrin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212127/ https://www.ncbi.nlm.nih.gov/pubmed/32395311 http://dx.doi.org/10.21037/jtd.2019.12.130 |
Ejemplares similares
-
Balancing Weight Loss and Sarcopenia in Elderly Patients With Peripheral Artery Disease
por: Kokkinidis, Damianos G., et al.
Publicado: (2019) -
Use of bioresorbable vascular scaffold: a meta-analysis of patients with coronary artery disease
por: Farag, Mohamed, et al.
Publicado: (2016) -
Body mass index and long-term outcomes in patients with chronic total occlusions undergoing retrograde endovascular revascularization of the infra-inguinal lower limb arteries
por: Januszek, Rafał, et al.
Publicado: (2021) -
Fully bioresorption of an Absorb bioresorbable vascular scaffold after scaffold restenosis
por: Goncalves-Ramírez, Luis R., et al.
Publicado: (2019) -
Dual antiplatelet therapy for secondary prevention of coronary artery disease
por: Degrauwe, Sophie, et al.
Publicado: (2017)